Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.
about
Sofosbuvir in the treatment of early HCV infection in HIV-infected men.Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.HCV reinfection incidence among individuals treated for recent infection.Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men
P2860
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Sofosbuvir and ribavirin for 6 ...... nfection: The DARE-C II study.
@en
type
label
Sofosbuvir and ribavirin for 6 ...... nfection: The DARE-C II study.
@en
prefLabel
Sofosbuvir and ribavirin for 6 ...... nfection: The DARE-C II study.
@en
P2093
P2860
P356
P1433
P1476
Sofosbuvir and ribavirin for 6 ...... nfection: The DARE-C II study.
@en
P2093
David Shaw
Edward Gane
Gail V Matthews
Gregory J Dore
Jason Grebely
Joe Sasadeusz
Kathy Petoumenos
Laurence Maire
Margaret Hellard
Philippa Marks
P2860
P304
P356
10.1002/HEP.28844
P407
P577
2016-09-17T00:00:00Z